Association of the p53 codon 72 polymorphism with colorectal cancer in South West of Iran

Scientific Research and Essays

Volumn 6, Issue 15, 2011, Pages 3148-3152

  Doosti, Abbas ^a   Zamani, Meghdad ^a   Dehkordi, Payam Ghasemi ^a   Taheri, Shahla ^b   Banitalebi, Mehdi ^c   Mahmoudzadeh, Mehdi ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHAHREKORD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; Iran; Nested PCR; p53 codon 72; Polymorphism

Indexed keywords

EID: 80051721908     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ara S, Lee PS, Hansen MF (1990). Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res., 18: 4961-4965.
2. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC (2000). The p53 Codon 72 Polymorphism and Lung Cancer Risk. Canc. Epidemiol. Biomarkers Prev., 9: 1037-1042.
3. Gryfe R, Bapat B, Gallinger S, Swallow C, Redston M, Couture J (1997). Molecular biology of colorectal cancer. Curr. Probl. Canc., 21(5): 233-299.
4. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, Shinoda M, Kodera Y, Yamamura Y, Hirai T, Kato T, Tajima K (2002). No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Canc. Lett., 181(1): 81-85.
5. Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A (2007). Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Canc. Genet. Cytogenet., 173: 38-42.
6. Khrunin AV, Tarskaia LA, Spitsyn VA Lylova OI, Bebyakova NA, Mikulich AI, Limborska SA (2005). p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude. Mol. Gen. Genomics., 272: 666-672
7. Langerod A, Bukholm IRK, Bregard A, Lonning PE, Andersen TI, Rognum TO, Meling GI, Lothe RA, Borresen-Dale AL (2002). The TP53 Codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Canc. Epidemiol. Biomarkers Prev., 11: 1684-1688.
8. Lung FW, Lee TM, Shu BC, Chang FH (2004). p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J. Canc. Res. Clin. Oncol., 130: 728-732.
9. Steele RJC (2006). Modern challenges in colorectal cancer. Sorgen. 4(5): 285-291.
10. Mammano E, Belluco C, Bonafe M, Olivieri F, Mugianesi E, Barbi C, Mishto M, Cosci M, Franceschi C, Lise M, Nitti D (2009). Association of p53 polymorphisms and colorectal cancer: Modulation of risk and progression. EJSO., 35(4): 415-419.
11. Mojtahedi Z, Haghshenas MR, Hosseini SV, Fattahi MJ, Ghaderi A (2010). p53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J. Canc., 47(1): 31-34.
12. Nikbahkt Dastjerdi M, Salehi M, Mohajeri MR, Morsali F, Mirmohammad Sadeghi H, Esfandiary E (2008). Evidence for an association of TP53 codon 72 polymorphism with sporadic colorectal cancer risk in Isfahan. JRMS, 13(6): 317-323.
13. Onrat ST, Ellidokuz E, Kupelioglu A, Durhan E (2009). Frequency of TP53 codon72 polymorphism in cases with colon cancer. Turk. J. Canc., 39(1): 5-10.
14. Oren M (1999). Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274(51): 36031-36034.
15. Perez LO, Abba MC, Dulout FN, Golijow CD (2006). Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J. Gastroenterol., 12(9):1426-1429.
16. Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF (1992). Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int. J. Canc., 50: 683-688.
17. Sayhan N, Yazici H, Budak M, Bitisik O, Dalay N (2001). P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res. Commun. Mol. Pathol. Pharmacol., 109: 25-34.
18. Schneider-Stock R, Boltze C, Peters B, Szibor R, Landt O, Meyer F, Roessner A (2004). Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia. 6(5): 529-535.
19. Soong R, Powell B, Elsaleh H, Gnanasampanthan G, Smith DR, Goh HS, Joseph D, Iacopetta B (2000). Prognostic signicance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur. J. Canc., 36: 2053-2060.
20. Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, Zhu G (2007). Association of the TP53 Codon 72 Polymorphism with colorectal cancer in a Chinese population. Jpn. J. Clin. Oncol., 37(5): 385-390.